The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study

Abstract

BackgroundKnowledge of the epidemiology of adverse drug events (ADEs) and medication errors in psychiatric inpatients is limited outside Western countries. The nature of ADEs and medication errors are important for improving the quality of care worldwide; therefore, we conducted the Japan Adverse Drug Events Study, a series of cohort studies at several settings in Japan.MethodsThis report included 448 inpatients with 22,733 patient-days in a psychiatric hospital and psychiatric units at a tertiary care teaching hospital over 1 year. Four psychiatrists and two other physicians reviewed all medical charts and related documents to identify suspected incidents. The physicians later classified those incidents into ADEs, potential ADEs, medication errors, or exclusions and evaluated the severity and preventability if the incidents were events.ResultsDuring the study period, we identified 955 ADEs and 398 medication errors (incidence: 42.0 and 17.5 per 1000 patient-days, respectively). Among ADEs, 1.4 %, 28 %, and 71 % were life-threatening, serious, and significant, respectively. Antipsychotics were associated with half of all ADEs. The incidence of medication errors was higher in medical care units than in acute and nursing care units (40.9, 15.6, and 17.4 per 1000 patient-days, respectively). The monitoring and ordering stages were the most common error stages (39 % and 34 % of all medication errors, respectively), and 76 % of medication errors with ADEs were found at the monitoring stage. Non-psychiatric drugs were three times as likely to cause ADEs with errors compared to psychiatric drugs.ConclusionsAntipsychotic use, inadequate monitoring, and treatment of physical ailments by psychiatrists may contribute to the high incidence of medication errors and ADEs among psychiatric inpatients in Japan. Psychiatrists should be cautious in prescribing antipsychotics or unfamiliar medications for physical problems in their psychiatric patients, and should monitor patients after medication administration.

Adverse events in psychiatry: a national cohort study in Sweden with a unique psychiatric trigger tool

“…This result can be compared with the American Psychiatric Association's action for patient safety [27], which estimated that half of drugrelated AEs could have been prevented. Non-psychiatric drugs are associated with preventable AEs more often than psychiatric drugs [28,29].…”

Drug-drug interactions and pharmacists’ interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia

“…Studies evaluating the incidence of ADEs and medication errors in psychiatric inpatients in non-Western countries are scarce. An epidemiological study in psychiatric healthcare centers in Japan reported an incidence of 17.5 medical errors per 1000 patient-days (Ayani et al, 2016), but the specific information regarding the occurrence of DDIs was not made available. Similar studies in countries of the Middle East were not undertaken thus far and the current work begins to address this unmet need.…”

Monitoring of patients treated with lithium for bipolar disorder: an international survey

“…Mood stabilizers play a pivotal role in the long-term treatment of patients with bipolar disorder. While it is known that mood stabilizers effectively treat symptoms of bipolar disorder, the potential for adverse drug events (ADEs) is of concern (Rothschild et al 2007 ; Ayani et al 2016 ; Mann et al 2008 ). Some ADEs are preventable, and steps to minimize errors are needed to improve patient safety (Leendertse et al 2008 ).…”